HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil/lymphocyte ratio.

AbstractBACKGROUND:
Low-dose flutamide-metformin (Flu-Met) with an oral contraceptive is a therapeutic option for women with hyperinsulinaemic hyperandrogenism. We questioned (i) whether Flu-Met maintains efficacy if given discontinuously; (ii) how the efficacy of discontinuous Flu-Met plus a transdermal contraceptive compares with Flu-Met plus oral contraceptive; and (iii) whether these treatments also lower circulating C-reactive protein (CRP) and tumour necrosis factor alpha (TNF-alpha) and the high neutrophil/lymphocyte ratio.
METHODS:
Non-obese, young patients (n = 31) with hyperinsulinaemic hyperandrogenism were started on Flu-Met (21/28 days) and randomized to receive in addition either a drospirenone oral contraceptive or a transdermal contraceptive for 6 months.
RESULTS:
The effects of Flu-Met were similar whether combined with oral or transdermal contraceptive. In both groups, CRP and TNF-alpha levels fell and the high neutrophil/lymphocyte ratio normalized (P < 0.001). Lean body mass increased (P < 0.001) in both groups but, in contrast to earlier experience with continuous Flu-Met, fat mass failed to decrease in either group.
CONCLUSIONS:
Flu-Met seems less lipolytic, if given for only 21 days in every 28-day period. The efficacy of Flu-Met is comparable when combined with an oral contraceptive or a transdermal contraceptive. The range of Flu-Met effects may henceforth include lower levels of CRP and TNF-alpha, and a normalization of the neutrophil/lymphocyte ratio.
AuthorsLourdes Ibáñez, Carme Valls, Francis de Zegher
JournalHuman reproduction (Oxford, England) (Hum Reprod) Vol. 21 Issue 2 Pg. 451-6 (Feb 2006) ISSN: 0268-1161 [Print] England
PMID16239318 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Contraceptive Agents, Female
  • Contraceptives, Oral
  • Tumor Necrosis Factor-alpha
  • Flutamide
  • C-Reactive Protein
  • Metformin
Topics
  • Administration, Cutaneous
  • Adolescent
  • Adult
  • C-Reactive Protein (analysis)
  • Contraceptive Agents, Female (administration & dosage, therapeutic use)
  • Contraceptives, Oral (administration & dosage, therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Flutamide (administration & dosage, therapeutic use)
  • Humans
  • Hyperandrogenism (blood, drug therapy)
  • Hyperinsulinism (blood, drug therapy)
  • Leukocyte Count
  • Lymphocytes (drug effects)
  • Metformin (administration & dosage, therapeutic use)
  • Neutrophils (drug effects)
  • Tumor Necrosis Factor-alpha (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: